Anthropic confidentially files for IPO: Here's what it means
Anthropic announced today that it had " confidentially submitted a draft registration statement on Form S-1 to the U.S. Securities and Exchange Commission for a proposed initial public offering of our common stock." An S-1 is the registration document a company files with regulators before it
Netflix Stock Price Soars After Earnings Report Record New Memberships
Netflix stock price ( NASDAQ: NFLX ) is up more than 13% in the after-hours following its release of the fourth-quarter earnings report for fiscal year 2024. The streaming company recorded a 16% increase in revenue year-over-year, reaching 19% on a foreign exchange (F/X) neutral basis, which the
Vivos Therapeutics Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing
GlobeNewswire Inc.
9 minutes ago
LITTLETON, Colo., June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and associ
Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference
GlobeNewswire Inc.
10 minutes ago
TARRYTOWN, N.Y., June 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will participate in a fireside chat at the Oppenheimer 26th Annual Consumer Growth and E-Commerce Conference virtually on Monday,
DiagnosTear Achieves Major Scientific Milestone with Publication of TeaRx(TM) Clinical Study in Current Eye Research Journal
Newsfile
24 minutes ago
Publication in a leading peer-reviewed ophthalmology journal further validates TeaRx™ as a novel point-of-care platform for diagnosis, patient stratification, and prediction of responsiveness to therapy in Dry Eye Disease https://pubmed.ncbi.nlm.nih.
Nuwellis Announces Pricing of $6 Million Public Offering
GlobeNewswire Inc.
24 minutes ago
MINNEAPOLIS, June 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announces the pricing of a public offering of 20,000,000 shar
Blink Charging Announces Strategic Sale of Envoy to Blade Ranger to Advance Focus on Core Charging Infrastructure
GlobeNewswire Inc.
24 minutes ago
Transaction underscores shift to a focused, operator-led model centered on reliability, utilization, and financial performance Bowie, MD, June 05, 2026 (GLOBE NEWSWIRE) -- Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global
EVA Live launches FastQuoteDirect, it’s AI-Powered Consumer Engagement Platform Across 5.6 Billion Dollar Market
GlobeNewswire Inc.
24 minutes ago
LOS ANGELES, CA, June 05, 2026 (GLOBE NEWSWIRE) -- EVA Live, Inc. (NASDAQ: GOAI) EVA Live Product Update: FastQuoteDirect.com (FQD) is pleased to announce the deployment of its next-generation AI-powered customer engagement platform, powered by EVA L
Protium Clean Energy Corp. Enters Agreement to Acquire Emma and Ten O'Clock Property
Newsfile
24 minutes ago
Toronto, Ontario--(Newsfile Corp. - June 5, 2026) - Protium Clean Energy Corp. (CSE: GRUV) (the "Company") announces that it has entered into a property purchase and sale agreement (the "Acquisition Agreement") with the beneficial owners (the "Seller
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™
GlobeNewswire Inc.
24 minutes ago
Kennewick, WA, June 05, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a company pioneering Precision Radionuclide Therapy™ (PRnT) with its innovative RadioGel® technology, today announced the submission of its Early Feasibility IDE application t
Independent Market Research Finds Strong Physician Intent to Prescribe Moleculin's Annamycin in Relapsed/Refractory AML
GlobeNewswire Inc.
25 minutes ago
Surveyed oncologists reported high likelihood to prescribe (6 of 7), citing deep remissions, transplant-bridging potential, biomarker-agnostic use and reduced cardiotoxicity as key drivers Parallel survey of payers shows strong support for Annamycin
Ocean Power Technologies Announces Pricing of $10,000,000 Registered Direct Offering Priced At A Premium to Market
GlobeNewswire Inc.
39 minutes ago
MONROE TOWNSHIP, N.J., June 05, 2026 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), today announced that it has entered into securities purchase agreements with certain institutional investors for t
